SCHEMBL21929285

SCHEMBL21929285

Cc1cccc(-c2ccc3c4ccc(-c5cccc(C)c5)cc4n(-c4cncc(-n5c6cc(-c7cccc(C)c7)ccc6c6ccc(-c7cccc(C)c7)cc65)c4-c4ccc(C#N)cc4)c3c2)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.46
CYP11B1 P15538 3/20 0.46
CHEK1 O14757 1/20 0.42
MAPK14 Q16539 1/20 0.41
AR P10275 3/20 0.36
KDM1A O60341 1/20 0.36
GRIA2 P42262 1/20 0.35
GRIA4 P48058 1/20 0.35
GRIN2B Q13224 1/20 0.35
KDM4A O75164 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
GRM5 P41594 1/20 0.35
CYP17A1 P05093 1/20 0.34
FLT3 P36888 2/20 0.34
PIP4K2A P48426 1/20 0.34
MARK3 P27448 1/20 0.34
GSK3A P49840 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21929271 0.96 CYP11B2 (0.43) CYP11B2CYP11B1CHEK1MAPK14AR
SCHEMBL21928410 0.92 CYP11B1 (0.40) CYP11B2CYP11B1CHEK1MAPK14
SCHEMBL21929286 0.91 CYP11B2 (0.46) CYP11B2CYP11B1CHEK1MAPK14AR
SCHEMBL21928449 0.91 CHEK1 (0.43) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL21928421 0.89 CHEK1 (0.46) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL21928430 0.89 CHEK1 (0.41) CYP11B2CYP11B1CHEK1GRIN2BCYP17A1
SCHEMBL21931740 0.89 CHEK1 (0.40) CYP11B2CYP11B1CHEK1ARKDM1A
SCHEMBL21929266 0.89 CYP11B2 (0.43) CYP11B2CYP11B1CHEK1MAPK14AR
SCHEMBL24737203 0.88 CYP11B1 (0.38) CYP11B2CYP11B1GRIN2B
SCHEMBL21931767 0.88 GABRA1 (0.43) CYP11B2CYP11B1CHEK1ARCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 CYP11B2 902/4885CYP11B1 1431/4885CHEK1 3808/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA CYP11B2 163/4885CYP11B1 432/4885CHEK1 1237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.